Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000106

Chairperson & CEO sold 9,500 shares at an average $531.74 ($5,051,519)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-24 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $135.42 $1,286,490 333,943 I
2026-07-24 Sale : show line 2 in the form 10b5-1 −820 $528.72 $433,549 333,123 I
2026-07-24 Sale : show line 3 in the form 10b5-1 −2,285 $530.45 $1,212,080 330,838 I
2026-07-24 Sale : show line 4 in the form 10b5-1 −1,115 $531.10 $592,179 329,723 I
2026-07-24 Sale : show line 5 in the form 10b5-1 −2,719 $532.27 $1,447,229 327,004 I
2026-07-24 Sale : show line 6 in the form 10b5-1 −1,818 $533.20 $969,356 325,186 I
2026-07-24 Sale : show line 7 in the form 10b5-1 −630 $534.39 $336,668 324,556 I
2026-07-24 Sale : show line 8 in the form 10b5-1 −113 $535.03 $60,458 324,443 I
Open-market sales · 9,500 sh · avg $531.74 · $5,051,519

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-24 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option −9,500 274,910 I
Loading xslF345X06/primarydocument.xml…